| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | €84,9340 | +0,13 % | €1,23B | €180,17K | |
TMP Tompkins Financial Corporation | €83,5738 | +0,59 % | €1,23B | €248,95 | |
BRUN Boost Run Inc. Class A Common Stock | €16,5924 | +0,00 % | €1,23B | €2,37K | |
TWFG TWFG, Inc. Common Stock | €24,3304 | +0,00 % | €1,23B | €1,711 | |
PCT PureCycle Technologies, Inc. Common stock | €5,7746 | +0,00 % | €1,23B | €2,21K | |
REX REX American Resources Corp. | €37,9756 | +0,00 % | €1,23B | €89,68K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | €6,2537 | -0,27 % | €1,23B | €153,13 | |
BTT BlackRock Municipal 2030 Target Term Trust | €19,2573 | +0,00 % | €1,23B | €2,566 | |
ADNT Adient plc Ordinary Shares | €16,6737 | +0,00 % | €1,22B | €0,8555 | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | €23,0899 | -0,04 % | €1,22B | €1,57M | |
| €31,2875 | +0,92 % | €1,22B | €920,78K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | €2,8745 | +0,90 % | €1,22B | €2,57K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | €14,4237 | +0,00 % | €1,22B | €54,96K | |
REPL Replimune Group, Inc. | €12,0112 | -0,07 % | €1,22B | €159,12 | |
HCSG Healthcare Services Group | €19,6594 | -0,09 % | €1,22B | €503,58K | |
